|
Volumn 18, Issue 17, 2000, Pages 3093-3100
|
Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOXORUBICIN;
DOXORUBICIN LIPID COMPLEX;
LIPOSOME;
MITOMYCIN;
NITROSOUREA;
PACLITAXEL;
PLATINUM;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
ASTHENIA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG COATING;
DYSESTHESIA;
EDEMA;
FEMALE;
HEART DISEASE;
HUMAN;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEUTROPENIA;
OVARY CANCER;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RECURRENCE RISK;
REFRACTORY PERIOD;
STOMATITIS;
TREATMENT OUTCOME;
|
EID: 0033850066
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2000.18.17.3093 Document Type: Article |
Times cited : (321)
|
References (21)
|